- BENF Dashboard
-
Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Beneficient (BENF) Financial statements
Company Profile
Mar 2024 | Mar 2023 | ||
---|---|---|---|
Total Revenue | |||
Cost of Revenue | |||
Gross Profit | |||
Gross Profit Margin (%) | |||
R&D Expense | |||
SG&A Expense | |||
Total Operating Expenses | |||
Operating Income or Loss | |||
Operating Margin (%) | |||
Interest Expense | |||
Total Other Income/Expenses | |||
Income Before Tax | |||
Income Tax Expense | |||
Income from Continuing Ops. | |||
Net Income | |||
Net Profit Margin (%) | |||
Net Income Available to Common Shareholders | |||
Basic EPS | |||
Diluted EPS | |||
Basic Average Shares | |||
Diluted Average Shares |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | ||
---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||
Cost of Revenue | ||||||||
Gross Profit | ||||||||
Gross Profit Margin (%) | ||||||||
R&D Expense | ||||||||
SG&A Expense | ||||||||
Total Operating Expenses | ||||||||
Operating Income or Loss | ||||||||
Operating Margin (%) | ||||||||
Interest Expense | ||||||||
Total Other Income/Expenses | ||||||||
Income Before Tax | ||||||||
Income Tax Expense | ||||||||
Income from Continuing Ops. | ||||||||
Net Income | ||||||||
Net Profit Margin (%) | ||||||||
Net Income Available to Common Shareholders | ||||||||
Basic EPS | ||||||||
Diluted EPS | ||||||||
Basic Average Shares | ||||||||
Diluted Average Shares |
Mar 2024 | Mar 2023 | ||
---|---|---|---|
Current Assets | |||
Cash & Cash Equivalents | |||
Marketable Securities | |||
Receivables | |||
Inventories | |||
Other Current Assets | |||
Total Current Assets | |||
Non-Current Assets | |||
Marketable Securities | |||
PPE Net | |||
Intangibles inc. Goodwill | |||
Other Non-Current Assets | |||
Total Non-Current Assets | |||
Total Assets | |||
Current Liabilities | |||
Accounts Payable | |||
Deferred Revenues | |||
Debt, Current | |||
Accrued Liabilities | |||
Other Current Liabilities | |||
Total Current Liabilities | |||
Non-Current Liabilities | |||
Deferred Revenues | |||
Debt, Non-Current | |||
Other Non-Current Liabilities | |||
Total Non-Current Liabilities | |||
Total Liabilities | |||
Shareholders' Equity | |||
Common Stock | |||
Additional Paid-In Capital | |||
Retained Earnings | |||
Other Shareholders' Equity | |||
Total Shareholders' Equity | |||
Total Liabilities & Shareholders' Equity |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | ||
---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||
Cash & Cash Equivalents | ||||||||
Marketable Securities | ||||||||
Receivables | ||||||||
Inventories | ||||||||
Other Current Assets | ||||||||
Total Current Assets | ||||||||
Non-Current Assets | ||||||||
Marketable Securities | ||||||||
PPE Net | ||||||||
Intangibles inc. Goodwill | ||||||||
Other Non-Current Assets | ||||||||
Total Non-Current Assets | ||||||||
Total Assets | ||||||||
Current Liabilities | ||||||||
Accounts Payable | ||||||||
Deferred Revenues | ||||||||
Debt, Current | ||||||||
Accrued Liabilities | ||||||||
Other Current Liabilities | ||||||||
Total Current Liabilities | ||||||||
Non-Current Liabilities | ||||||||
Deferred Revenues | ||||||||
Debt, Non-Current | ||||||||
Other Non-Current Liabilities | ||||||||
Total Non-Current Liabilities | ||||||||
Total Liabilities | ||||||||
Shareholders' Equity | ||||||||
Common Stock | ||||||||
Additional Paid-In Capital | ||||||||
Retained Earnings | ||||||||
Other Shareholders' Equity | ||||||||
Total Shareholders' Equity | ||||||||
Total Liabilities & Shareholders' Equity |
Mar 2024 | Mar 2023 | ||
---|---|---|---|
Cash Flows from Operating Activities | |||
Net Income | |||
Depreciation & Amortization | |||
Deferred Income Taxes | |||
Stock Based Compensation | |||
Accounts Receivable | |||
Inventory | |||
Accounts Payable | |||
Deferred Revenue | |||
Other Non-Cash | |||
Operating Cash Flow | |||
Cash Flows from Investing Activities | |||
PPE Investments | |||
Net Acquisitions | |||
Purchase of Investments | |||
Sale of Investments | |||
Other Investing Activity | |||
Investing Cash Flow | |||
Cash Flows from Financing Activities | |||
Debt Issued | |||
Proceeds from Debt Repayment | |||
Debt Repayment | |||
Proceeds from Sale of Equity | |||
Equity Repurchased | |||
Dividend Paid | |||
Other Financing Activity | |||
Financing Cash Flow | |||
Cash Position | |||
Beginning Cash Position | |||
End Cash Position | |||
Change in Cash | |||
Free Cash Flow | |||
Operating Cash Flow | |||
Capital Expenditure | |||
Free Cash Flow |
Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | ||
---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||
Net Income | ||||||||
Depreciation & Amortization | ||||||||
Deferred Income Taxes | ||||||||
Stock Based Compensation | ||||||||
Accounts Receivable | ||||||||
Inventory | ||||||||
Accounts Payable | ||||||||
Deferred Revenue | ||||||||
Other Non-Cash | ||||||||
Operating Cash Flow | ||||||||
Cash Flows from Investing Activities | ||||||||
PPE Investments | ||||||||
Net Acquisitions | ||||||||
Purchase of Investments | ||||||||
Sale of Investments | ||||||||
Other Investing Activity | ||||||||
Investing Cash Flow | ||||||||
Cash Flows from Financing Activities | ||||||||
Debt Issued | ||||||||
Proceeds from Debt Repayment | ||||||||
Debt Repayment | ||||||||
Proceeds from Sale of Equity | ||||||||
Equity Repurchased | ||||||||
Dividend Paid | ||||||||
Other Financing Activity | ||||||||
Financing Cash Flow | ||||||||
Cash Position | ||||||||
Beginning Cash Position | ||||||||
End Cash Position | ||||||||
Change in Cash | ||||||||
Free Cash Flow | ||||||||
Operating Cash Flow | ||||||||
Capital Expenditure | ||||||||
Free Cash Flow |